• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传性出血性疾病合并丙型肝炎患者进展至终末期肝病:一项国际多中心队列研究。

Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study.

作者信息

Posthouwer Dirk, Makris Michael, Yee Thynn T, Fischer Kathelijn, van Veen Joost J, Griffioen Anja, van Erpecum Karel J, Mauser-Bunschoten Eveline P

机构信息

Van Creveldkliniek, University Medical Center Utrecht, The Netherlands.

出版信息

Blood. 2007 May 1;109(9):3667-71. doi: 10.1182/blood-2006-08-038349. Epub 2007 Jan 9.

DOI:10.1182/blood-2006-08-038349
PMID:17213288
Abstract

Prior to 1990, many patients with inherited bleeding disorders were infected with hepatitis C virus (HCV). This study assessed the risk of end-stage liver disease (ESLD) in patients with hemophilia with chronic hepatitis C. Patients were infected between 1961 and 1990 and were followed up to August 2005. Of 847 anti-HCV(+) patients, 160 (19%) spontaneously cleared HCV and 687 (81%) developed chronic hepatitis C. Coinfection with HIV was present in 210 patients. After 35 years of infection the cumulative incidence of ESLD was 11.5% (95% CI, 8.2%-14.8%) in HIV(-) patients and 35.1% (95% CI, 29.2%-41.0%; P < .001) in patients coinfected with HIV. Independent risk factors of ESLD were HIV coinfection (hazard ratio 13.8; 95% CI, 7.5-25.3), older age at infection (hazard ratio 2.3 per 10 years; 95% CI, 2.0-2.8), alcohol abuse (hazard ratio 4.9; 95% CI, 2.5-9.6), and presence of HCV genotype 1 (hazard ratio 2.2; 95% CI, 1.1-4.2). With longer duration of HCV infection, the risk of developing ESLD is emerging in patients with inherited bleeding disorders. Risk factors for rapid progression to ESLD are alcohol abuse, coinfection with HIV, older age at infection, and presence of HCV genotype 1.

摘要

1990年以前,许多遗传性出血性疾病患者感染了丙型肝炎病毒(HCV)。本研究评估了慢性丙型肝炎血友病患者发生终末期肝病(ESLD)的风险。患者于1961年至1990年间感染,并随访至2005年8月。在847例抗HCV(+)患者中,160例(19%)自发清除HCV,687例(81%)发展为慢性丙型肝炎。210例患者合并感染HIV。感染35年后,HIV(-)患者ESLD的累积发病率为11.5%(95%CI,8.2%-14.8%),合并感染HIV的患者为35.1%(95%CI,29.2%-41.0%;P<0.001)。ESLD的独立危险因素为合并感染HIV(风险比13.8;95%CI,7.5-25.3)、感染时年龄较大(每10年风险比2.3;95%CI,2.0-2.8)、酗酒(风险比4.9;95%CI,2.5-9.6)以及存在HCV基因型1(风险比2.2;95%CI,1.1-4.2)。随着HCV感染时间延长,遗传性出血性疾病患者发生ESLD的风险正在显现。快速进展至ESLD的危险因素为酗酒、合并感染HIV、感染时年龄较大以及存在HCV基因型1。

相似文献

1
Progression to end-stage liver disease in patients with inherited bleeding disorders and hepatitis C: an international, multicenter cohort study.遗传性出血性疾病合并丙型肝炎患者进展至终末期肝病:一项国际多中心队列研究。
Blood. 2007 May 1;109(9):3667-71. doi: 10.1182/blood-2006-08-038349. Epub 2007 Jan 9.
2
Long-term follow-up of hepatitis C infection in a large cohort of patients with inherited bleeding disorders.遗传性出血性疾病患者中丙型肝炎感染的长期随访。
J Hepatol. 2014 Jan;60(1):39-45. doi: 10.1016/j.jhep.2013.08.010. Epub 2013 Aug 23.
3
End-stage liver disease in persons with hemophilia and transfusion-associated infections.血友病患者的终末期肝病与输血相关感染
Blood. 2002 Sep 1;100(5):1584-9.
4
Lack of association of hepatitis C virus load and genotype with risk of end-stage liver disease in patients with human immunodeficiency virus coinfection.丙型肝炎病毒载量和基因型与人类免疫缺陷病毒合并感染患者终末期肝病风险之间无关联。
J Infect Dis. 2001 Nov 1;184(9):1202-5. doi: 10.1086/323665. Epub 2001 Sep 13.
5
Long term survival in persons with hemophilia and chronic hepatitis C: 40 year outcomes of a large single center cohort.血友病合并慢性丙型肝炎患者的长期生存:一个大型单中心队列的40年随访结果
Am J Hematol. 2016 Sep;91(9):E335-40. doi: 10.1002/ajh.24427. Epub 2016 Jul 14.
6
HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis.HIV合并感染会缩短丙型肝炎病毒相关失代偿性肝硬化患者的生存期。
Hepatology. 2005 Apr;41(4):779-89. doi: 10.1002/hep.20626.
7
Infection With Hepatitis C Virus Genotype 3 Is an Independent Risk Factor for End-Stage Liver Disease, Hepatocellular Carcinoma, and Liver-Related Death.丙型肝炎病毒3型感染是终末期肝病、肝细胞癌和肝脏相关死亡的独立危险因素。
Clin Gastroenterol Hepatol. 2017 Mar;15(3):431-437.e2. doi: 10.1016/j.cgh.2016.10.012. Epub 2016 Oct 17.
8
Liver decompensation in HIV/Hepatitis B coinfection in the combination antiretroviral therapy era does not seem increased compared to hepatitis B mono-infection.在联合抗病毒治疗时代,HIV/乙型肝炎病毒合并感染导致的肝功能失代偿似乎并不比乙型肝炎病毒单感染更常见。
Liver Int. 2019 Mar;39(3):470-483. doi: 10.1111/liv.14000. Epub 2018 Dec 2.
9
Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment.人类免疫缺陷病毒和丙型肝炎病毒合并感染患者的临床结局:丙型肝炎病毒治疗的影响。
Clin Infect Dis. 2020 May 6;70(10):2131-2140. doi: 10.1093/cid/ciz601.
10
The natural history of hepatitis C virus infection: host, viral, and environmental factors.丙型肝炎病毒感染的自然史:宿主、病毒和环境因素。
JAMA. 2000 Jul 26;284(4):450-6. doi: 10.1001/jama.284.4.450.

引用本文的文献

1
Adeno-associated virus and hepatocytes: frenemies?腺相关病毒与肝细胞:亦敌亦友?
Blood Adv. 2024 Oct 8;8(19):5200-5202. doi: 10.1182/bloodadvances.2024013845.
2
Hepatitis C Virus Infections in Patients with Hemophilia: Links, Risks and Management.血友病患者的丙型肝炎病毒感染:关联、风险与管理
J Multidiscip Healthc. 2022 Oct 10;15:2301-2309. doi: 10.2147/JMDH.S363177. eCollection 2022.
3
Liver-related complications before and after successful treatment of chronic hepatitis C virus infection in people with inherited bleeding disorders.
遗传性出血性疾病患者慢性丙型肝炎病毒感染成功治疗前后的肝脏相关并发症。
Haemophilia. 2023 Jan;29(1):106-114. doi: 10.1111/hae.14668. Epub 2022 Oct 2.
4
Implementation of Microelimination Strategy in Eradication of Chronic Hepatitis C Infection in Patients with Hemophilia in the Northern region of Serbia: Is Eradication Possible?塞尔维亚北部地区血友病患者慢性丙型肝炎感染根除中微消除策略的实施:根除是否可行?
Mediterr J Hematol Infect Dis. 2021 Sep 1;13(1):e2021058. doi: 10.4084/MJHID.2021.058. eCollection 2021.
5
Long-Term Follow-Up of a Portuguese Single-Centre Cohort of Persons with Haemophilia and Hepatitis C Virus Infection.葡萄牙单中心血友病合并丙型肝炎病毒感染患者队列的长期随访
GE Port J Gastroenterol. 2021 Feb;28(2):79-86. doi: 10.1159/000510023. Epub 2020 Sep 29.
6
Hepatitis C viral infection in patients with hemophilia and hemolytic disorders.血友病和溶血性疾病患者中的丙型肝炎病毒感染
Clin Liver Dis (Hoboken). 2012 Jul 23;1(3):95-97. doi: 10.1002/cld.42. eCollection 2012 Jul.
7
The elevated prevalence of risk factors for chronic liver disease among ageing people with hemophilia and implications for treatment.老年血友病患者慢性肝病危险因素的高患病率及其对治疗的影响。
Medicine (Baltimore). 2018 Sep;97(39):e12551. doi: 10.1097/MD.0000000000012551.
8
Complete correction of hemophilia B phenotype by FIX-Padua skeletal muscle gene therapy in an inhibitor-prone dog model.FIX-Padua 骨骼肌基因治疗纠正血友病 B 表型,抑制物倾向犬模型。
Blood Adv. 2018 Mar 13;2(5):505-508. doi: 10.1182/bloodadvances.2017015313.
9
Hepatitis C infection in patients with hereditary bleeding disorders: epidemiology, natural history, and management.遗传性出血性疾病患者的丙型肝炎感染:流行病学、自然史及管理
Ann Gastroenterol. 2018 Jan-Feb;31(1):35-41. doi: 10.20524/aog.2017.0204. Epub 2017 Oct 26.
10
Management of Hemophilia in Older Patients.老年血友病患者的管理
Drugs Aging. 2017 Dec;34(12):881-889. doi: 10.1007/s40266-017-0500-8.